Skip to content
FDA Issues Draft Guidance for Conducting Clinical Trials With Psychedelic Substances
6/27/23 12:00 AM
Psychiatrists Outline Ethical Considerations Related to Psychedelics
4/5/23 12:00 AM
Use of Psychedelic Substances May Raise Risk of Seizures
8/12/22 12:00 AM
Guardrails Needed to Control Promotion, Off-label Use of Psychedelics
7/5/22 12:00 AM
First
Prev
1
2
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Follow us on X
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Subscribe Here!
News From Current Issue
Special Report: Communicating the Neurobiology of MDD
Why Narcolepsy Is Often Missed—and How to Spot It
Integrating Psychiatric Pharmacists Into Practice
Read This Week's Update
